Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 990 | 200 | 782 |
| Samples | 891 | 170 | 714 |
| Peptides | 654 | 121 | 549 |
Function
TMPRSS15 · Transmembrane serine protease 15
This gene encodes an enzyme that converts the pancreatic proenzyme trypsinogen to trypsin, which activates other proenzymes including chymotrypsinogen and procarboxypeptidases. The precursor protein is cleaved into two chains that form a heterodimer linked by a disulfide bond. This protein is a member of the trypsin family of peptidases. Mutations in this gene cause enterokinase deficiency, a malabsorption disorder characterized by diarrhea and failure to thrive. [provided by RefSeq, Jul 2008].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000284885 | P98073 | 990 | 654 |
Gene Properties
Recurrent Mutations
All 654 amino-acid changes on canonical ENST00000284885 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in TMPRSS15 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TMPRSS15 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Cell Non-Hodgkins Lymphoma | 3/26 12% | 0/0 0% |
| T-Lymphoblastic Leukemia | 4/40 10% | 0/0 0% |
| Non-Small Cell Lung Carcinoma | 50/304 16% | 61/1390 4% |
| Endometrial Carcinoma | 4/42 10% | 31/612 5% |
| Squamous Cell Lung Carcinoma | 3/57 5% | 43/810 5% |
| Melanoma | 9/210 4% | 99/1899 5% |
| Acute Myeloid Leukemia | 4/90 4% | 0/0 0% |
| Chronic Myelogenous Leukemia | 1/25 4% | 0/0 0% |
| Other Solid Cancers | 10/94 11% | 52/1515 3% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 5/133 4% |
| Small Cell Lung Carcinoma | 0/9 0% | 26/752 3% |
| Gastric Carcinoma | 5/74 7% | 54/1809 3% |
| Colorectal Carcinoma | 15/143 10% | 79/3239 2% |
| Bladder Carcinoma | 5/58 9% | 22/956 2% |
| Neuroendocrine Tumour | 7/154 5% | 8/577 1% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Osteosarcoma | 3/45 7% | 1/166 1% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Ewings Sarcoma | 4/63 6% | 1/262 0% |
| Esophageal Carcinoma | 0/23 0% | 12/769 2% |
| Ovarian Carcinoma | 5/109 5% | 11/998 1% |
| Hodgkins Lymphoma | 0/16 0% | 2/122 2% |
| Other Sarcomas | 3/69 4% | 7/699 1% |
| Non-Cancerous | 0/104 0% | 12/830 1% |
| Esophageal Squamous Cell Carcinoma | 3/51 6% | 29/2550 1% |
| Glioma | 0/52 0% | 26/2127 1% |
| Biliary Tract Carcinoma | 0/54 0% | 11/950 1% |
| Head and Neck Carcinoma | 6/85 7% | 11/1574 1% |
| Hepatocellular Carcinoma | 0/46 0% | 21/2210 1% |
| Cervical Carcinoma | 0/35 0% | 4/422 1% |
Mutation Distribution
Where TMPRSS15 is mutated · all tissues, split by cell line vs tissue
How many mutations in TMPRSS15 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 19 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 990 mutations in TMPRSS15
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|